Koers Spring Pharmaceutical Group, Inc.
Aandelen
BYC
US84987P1057
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Chuan Min Li
DFI | Director of Finance/CFO | 59 | 01-01-05 |
Qiang Zhang
ADM | Chief Administrative Officer | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Ji Rui Zhang
BRD | Director/Board Member | 68 | 01-01-04 |
Director/Board Member | 73 | 06-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,07% | 816 mld. | |
+38,59% | 634 mld. | |
-7,05% | 351 mld. | |
+15,44% | 323 mld. | |
+5,72% | 293 mld. | |
+13,40% | 238 mld. | |
+0,61% | 222 mld. | |
+13,24% | 218 mld. | |
+7,42% | 167 mld. |